Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
General Thoracic and Cardiovascular Surgery
Erschienen in: General Thoracic and Cardiovascular Surgery 4/2016

01.04.2016 | Current Topics Review Article

Contemporary mechanical circulatory support therapy for postcardiotomy shock

verfasst von: Shinichi Fukuhara, Koji Takeda, Arthur Reshad Garan, Paul Kurlansky, Jonathan Hastie, Yoshifumi Naka, Hiroo Takayama

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Significant progress has been made in the use of mechanical circulatory support (MCS), particularly in the clinical success in durable left ventricular assist device. Short-term MCS has also advanced in the form of venoarterial extracorporeal membrane oxygenation, external centrifugal VADs as well as percutaneous VADs. Postcardiotomy shock (PCS) is a rare clinical entity associated with substantial morbidity and mortality. It is characterized by heart failure that either results in an inability to wean from cardiopulmonary bypass or that occurs in the immediate postoperative period, accounting for the most common indication for MCS. The reported in-hospital mortality of the PCS patients remains high, consistently over 50 %, despite ongoing refinements of MCS technology. The optimization of selection criteria and the prompt institution of MCS are likely the keys to improving this persistently high mortality rate. Unfortunately, the lack of a clear definition for PCS in the literature limits scientific analyses and comparison of the existing evidence. To establish the treatment strategy and appropriately manage this challenging disease, substantial and fundamental effort by the cardiovascular society is imperative.
Literatur
1.
Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2011;59:636–67.CrossRefPubMed
2.
Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Results of mechanical ventricular assistance for the treatment of post cardiotomy cardiogenic shock. ASAIO J. 1996;42:211–8.PubMed
3.
Paul S, Leacche M, Unic D, Couper GS, Macgillivray TE, Agnihotri AK, Cohn LH, et al. Determinants of outcomes for postcardiotomy VAD placement: an 11-year, two-institution study. J Card Surg. 2006;21:234–7.CrossRefPubMed
4.
Curtis JJ, McKenney-Knox CA, Wagner-Mann CC. Postcardiotomy centrifugal assist: a single surgeon’s experience. Artif Organs. 2002;26:994–7.CrossRefPubMed
5.
Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302.CrossRefPubMed
6.
Saxena P, Neal J, Joyce LD, Greason KL, Schaff HV, Guru P, et al. Extracorporeal membrane oxygenation support in postcardiotomy elderly patients: the Mayo Clinic experience. Ann Thorac Surg. 2015;99:2053–60.CrossRefPubMed
7.
Teman NR, Demos DS, Reames BN, Pagani FD, Haft JW. Outcomes after transfer to a tertiary center for postcardiotomy cardiopulmonary failure. Ann Thorac Surg. 2014;98:84–9.CrossRefPubMed
8.
Truby L, Mundy L, Kalesan B, Kirtane A, Colombo PC, Takeda K, et al. Contemporary outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock at a large tertiary care center. ASAIO J. 2015;61:403–9.CrossRefPubMed
9.
Hernandez AF, Grab JD, Gammie JS, O’Brien SM, Hammill BG, Rogers JG, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation. 2007;116:606–12.CrossRefPubMed
10.
Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, Khalpey Z, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014;7:799–806.CrossRefPubMedPubMedCentral
11.
Sylvin EA, Stern DR, Goldstein DJ. Mechanical support for postcardiotomy cardiogenic shock: has progress been made? J Card Surg. 2010;25:442–54.CrossRefPubMed
12.
Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: a retrospective observational study. J Thorac Cardiovasc Surg. 2015;149:1445–50.CrossRefPubMed
13.
Flécher E, Anselmi A, Corbineau H, Langanay T, Verhoye JP, Félix C, et al. Current aspects of extracorporeal membrane oxygenation in a tertiary referral centre: determinants of survival at follow-up. Eur J Cardiothorac Surg. 2014;46:665–71.CrossRefPubMed
14.
Gottfried R, Paluszkiewicz L, Kizner L, Morshuis M, Koertke H, Gummert J. Thrombosis of a bioprosthetic mitral valve under extracorporeal membrane oxygenation: thrombus formation in the left heart. Ann Thorac Surg. 2012;94:657.CrossRefPubMed
15.
Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002;106:I203–6.CrossRefPubMed
16.
Magovern GJ, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg. 1999;68:655–61.CrossRefPubMed
17.
Lemaire A, Anderson MB, Lee LY, Scholz P, Prendergast T, Goodman A, Lozano AM, Spotnitz A, Batsides G. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 2014;97:133–8.CrossRefPubMed
18.
Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145:548–54.CrossRefPubMed
19.
Doll N, Kiaii B, Borger M, Bucerius J, Krämer K, Schmitt DV, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;77:151–7.CrossRefPubMed
20.
Fiser SM, Tribble CG, Kaza AK, Long SM, Zacour RK, Kern JA, et al. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg. 2001;71:210–4.CrossRefPubMed
21.
Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 2002;73:538–45.CrossRefPubMed
22.
Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg. 2001;71:S77–81.CrossRefPubMed
23.
Smith C, Bellomo R, Raman JS, Matalanis G, Rosalion A, Buckmaster J, et al. An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. Ann Thorac Surg. 2001;71:1421–7.CrossRefPubMed
24.
Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg. 2001;71(3 Suppl):S82–5, S60–6.
25.
Bakhtiary F, Keller H, Dogan S, Dzemali O, Oezaslan F, Meininger D, et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg. 2008;135:382–8.CrossRefPubMed
26.
Zhang R, Kofidis T, Kamiya H, Shrestha M, Tessmann R, Haverich A, et al. Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg. 2006;30:617–20.CrossRefPubMed
27.
Pokersnik JA, Buda T, Bashour CA, Gonzalez-Stawinski GV. Have changes in ECMO technology impacted outcomes in adult patients developing postcardiotomy cardiogenic shock? J Card Surg. 2012;27:246–52.CrossRefPubMed
28.
Takayama H, Landes E, Truby L, Fujita K, Kirtane AJ, Mongero L, et al. Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2015;149:1428–33.CrossRefPubMed
29.
Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97:610–6.CrossRefPubMed
30.
Park SC, Neches WH, Mullins CE, Girod DA, Olley PM, Falkowski G, et al. Blade atrial septostomy: collaborative study. Circulation. 1982;66:258–66.CrossRefPubMed
31.
Barbone A, Malvindi PG, Ferrara P, Tarelli G. Left ventricle unloading by percutaneous pigtail during extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg. 2011;13:293–5.CrossRefPubMed
32.
Cheng A, Swartz MF, Massey HT. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013;59:533–6.CrossRefPubMed
33.
John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.CrossRefPubMed
34.
Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg. 2000;12:220–8.CrossRefPubMed
35.
Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126:2648–67.CrossRefPubMed
36.
Guyton RA, Schonberger JP, Everts PA, Jett GK, Gray LA Jr, Gielchinsky I, et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg. 1993;56:346–56.CrossRefPubMed
37.
Takayama H, Naka Y, Jorde UP, Stewart AS. Less invasive left ventricular assist device placement for difficult resternotomy. J Thorac Cardiovasc Surg. 2010;140:932–3.CrossRefPubMed
38.
Takayama H, Naka Y, Kodali SK, Vincent JA, Addonizio LJ, Jorde UP, Williams MR. A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg. 2012;41:423–6.CrossRefPubMed
39.
Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the centrimag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–1.CrossRefPubMed
40.
Mohite PN, Zych B, Popov AF, Sabashnikov A, Sáez DG, Patil NP, et al. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days. Eur J Cardiothorac Surg. 2013;44:e310–5.CrossRefPubMed
41.
Brinkman WT, Rosenthal JE, Eichhorn E, Dewey TM, Magee MJ, Savor DS, et al. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg. 2009;88:1462–6.CrossRefPubMed
42.
Siegenthaler MP, Brehm K, Strecker T, Hanke T, Nötzold A, Olschewski M, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg. 2004;127:812–22.CrossRefPubMed
43.
Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;77:1642–7.CrossRefPubMed
44.
Gregoric ID, Jacob LP, La Francesca S, Bruckner BA, Cohn WE, Loyalka P, et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J. 2008;35:125–9.PubMedPubMedCentral
45.
Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006;33:111–5.PubMedPubMedCentral
46.
Pitsis AA, Visouli AN, Burkhoff D, Dardas P, Mezilis N, Bougioukas G, Filippatos G. Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery. Ann Thorac Surg. 2007;84:1993–9.CrossRefPubMed
47.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33:555–64.CrossRefPubMed
48.
BoyleAJ AscheimDD, RussoMJ Kormos RL, JohnR NakaY, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by preoperative INTERMACS classification. J Heart Lung Transplant. 2011;30:402–7.CrossRef
49.
Pawale A, Pinney S, Ashley K, Flynn R, Milla F, Anyanwu AC. Implantable left ventricular assist devices as initial therapy for refractory postmyocardial infarction cardiogenic shock. Eur J Cardiothorac Surg. 2013;44:213–6.CrossRefPubMed
50.
Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS, et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14:288–93.CrossRefPubMed
51.
Akay MH, Gregoric ID, Radovancevic R, Cohn WE, Frazier OH. Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock. J Card Surg. 2011;26:548–52.CrossRefPubMed
52.
Javidfar J, Brodie D, Takayama H, Mongero L, Zwischenberger J, Sonett J, Bacchetta M. Safe transport of critically ill adult patients on extracorporeal membrane oxygenation support to a regional extracorporeal membrane oxygenation center. ASAIO J. 2011;57:421–5.CrossRefPubMed
53.
Baldwin RT, Slogoff S, Noon GP, Sekela M, Frazier OH, Edelman SK, et al. A model to predict survival at time of postcardiotomy intraaortic balloon pump insertion. Ann Thorac Surg. 1993;55:908–13.CrossRefPubMed
54.
Arafa OE, Pedersen TH, Svennevig JL, Fosse E, Geiran OR. Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg. 1998;65:741–7.CrossRefPubMed
55.
Wang SS, Chen YS, Ko WJ, Chu SH. Extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock. Artif Organs. 1996;20:1287–91.CrossRefPubMed
56.
Muehrcke DD, McCarthy PM, Stewart RW, Foster RC, Ogella DA, Borsh JA, et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg. 1996;61:684–91.CrossRefPubMed
57.
Körfer R, El-Banayosy A, Arusoglu L, Minami K, Breymann T, Seifert D, Kizner L. Temporary pulsatile ventricular assist devices and biventricular assist devices. Ann Thorac Surg. 1999;68:678–83.CrossRefPubMed
58.
Hoy FB, Mueller DK, Geiss DM, Munns JR, Bond LM, Linett CE, Gomez RC. Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? Ann Thorac Surg. 2000;70:1259–63.CrossRefPubMed
59.
Potapov EV, Loforte A, Weng Y, Jurmann M, Pasic M, Drews T, Loebe M, Hennig E, Krabatsch T, Koster A, Lehmkuhl HB, Hetzer R. Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008;23:185–94.CrossRefPubMed
60.
Hsu PS, Chen JL, Hong GJ, Tsai YT, Lin CY, Lee CY, Chen YG, Tsai CS. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg. 2010;37:328–33.PubMed
61.
Elsharkawy HA, Li L, Esa WA, Sessler DI, Bashour CA. Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24:946.CrossRefPubMed
62.
Wu MY, Lin PJ, Lee MY, et al. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival. Resuscitation. 2010;81:1111.CrossRefPubMed
63.
Loforte A, Pilato E, Martin Suarez S, Folesani G, Jafrancesco G, Castrovinci S, et al. RotaFlow and CentriMag extracorporeal membrane oxygenation support systems as treatment strategies for refractory cardiogenic shock. J Card Surg. 2015;30:201–8.CrossRefPubMed
Metadaten
Titel
Contemporary mechanical circulatory support therapy for postcardiotomy shock
verfasst von
Shinichi Fukuhara
Koji Takeda
Arthur Reshad Garan
Paul Kurlansky
Jonathan Hastie
Yoshifumi Naka
Hiroo Takayama
Publikationsdatum
01.04.2016
Verlag
Springer Japan
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 4/2016
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-016-0625-4

Weitere Artikel der Ausgabe 4/2016

General Thoracic and Cardiovascular Surgery 4/2016 Zur Ausgabe

Obituary

Jerome Harold Kay (17 March 1921–14 August 2015): a great innovator in cardiac surgery

Case Report

Successful subcarinal dissection using a laparoscopic transhiatal approach for esophageal cancer with an anomalous pulmonary vein

Original Article

Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis

Case Report

Management of an aorto-esophageal fistula, complicating a descending thoracic aortic aneurysm endovascularly repaired

Case Report

Difficult preoperative diagnosis in a case of rapidly progressive carcinomatous pericarditis

Current Topics Review Article

Approach for oligometastasis in non-small cell lung cancer

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise